Company / Working Capital
Haemonetics Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$356.9M
FY2025
5-year range
$313.8M / $517.9M
FY2021-FY2025
Trend
-23.8%
vs FY2024
Sector context
#87 of 165
Health Care
What the data says
At $357M, Haemonetics's working capital ranks #87 of 165 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $136M in FY2018 to $518M in FY2023.
Based on SEC 10-K filings.
$357M in FY2025 with a 5-year CAGR of +1.7%.
Declined from $518M to $357M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- +1.7%
- 10-Year CAGR
- -
Sector benchmark
#87 of 165 in Health CareTop 53% of 165This company $356.9M Sector average $836.2M
▼
-57.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.7%, indicating consistent growth.
- In FY2025, working capital decreased 23.8% year-over-year.
- Ranks #87 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $356.9M | -23.8% |
| FY2024 | $468.5M | -9.5% |
| FY2023 | $517.9M | +65.1% |
| FY2022 | $313.8M | -28.7% |
| FY2021 | $440.1M | +33.8% |
| FY2020 | $328.8M | -3.4% |
| FY2019 | $340.4M | +149.4% |
| FY2018 | $136.5M | -54.3% |
| FY2017 | $298.9M | -1.2% |
| FY2016 | $302.5M | -18.0% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026